U.S. Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: JUNE 6, 1996
MEDICAL ASSET MANAGEMENT, INC.
A Delaware Corporation
COMMISSION FILE NO. 0-27236 EIN: 33--0359976
4447 E. Broadway, Suite 102
Mesa, Arizona 85206
Telephone: 602-830-7414
<PAGE>
Item 1. N/A
Item 2. N/A
Item 3. N/A
Item 4. N/A
Item 5. Other Matters.
On May 31, 1996 the Company sold 2,000,000 shares of
restricted common stock to a group of 30 accredited investors
(as defined in Regulation D) for $ 8,000,000.00. The gross
proceeds less selling expenses will be used to reduce
indebtedness and increase working capital. Cruttenden Roth
Incorporated of Irvine, California was the selling agent. The
total number of issued and outstanding shares of common stock
prior to the private placement as of May 30, 1996 was
11,343,132.
Item 6. N/A
Item 7. Financial Statements and Exhibits.
Financial information is not yet available.
Item 8. N/A
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, this
registrant caused this registration statement to be signed on its behalf by
the undersigned, thereunto duly authorized.
MEDICAL ASSET MANAGEMENT, INC.
Dated: JUNE 6, 1996
By: /S/ JOHN REGAN
---------------------
John Regan, President
